- Home
- LFCR vs GLO Comparison
LFCR vs GLO Comparison
Compare LFCR & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- GLO
- Stock Information
- Founded
- LFCR 1986
- GLO 2006
- Country
- LFCR United States
- GLO United States
- Employees
- LFCR N/A
- GLO N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- LFCR Health Care
- GLO Finance
- Exchange
- LFCR Nasdaq
- GLO Nasdaq
- Market Cap
- LFCR 214.7M
- GLO 220.0M
- IPO Year
- LFCR N/A
- GLO N/A
- Fundamental
- Price
- LFCR $5.94
- GLO $5.28
- Analyst Decision
- LFCR Buy
- GLO
- Analyst Count
- LFCR 3
- GLO 0
- Target Price
- LFCR $8.00
- GLO N/A
- AVG Volume (30 Days)
- LFCR 239.5K
- GLO 170.5K
- Earning Date
- LFCR 01-02-2025
- GLO 01-01-0001
- Dividend Yield
- LFCR N/A
- GLO 11.38%
- EPS Growth
- LFCR N/A
- GLO N/A
- EPS
- LFCR N/A
- GLO N/A
- Revenue
- LFCR $130,858,000.00
- GLO N/A
- Revenue This Year
- LFCR $2.24
- GLO N/A
- Revenue Next Year
- LFCR $7.88
- GLO N/A
- P/E Ratio
- LFCR N/A
- GLO N/A
- Revenue Growth
- LFCR 16.47
- GLO N/A
- 52 Week Low
- LFCR $3.68
- GLO $4.08
- 52 Week High
- LFCR $8.90
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- LFCR 37.34
- GLO 47.76
- Support Level
- LFCR $5.80
- GLO $5.22
- Resistance Level
- LFCR $6.20
- GLO $5.35
- Average True Range (ATR)
- LFCR 0.28
- GLO 0.06
- MACD
- LFCR -0.04
- GLO -0.00
- Stochastic Oscillator
- LFCR 6.40
- GLO 27.50
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.